Historical record - last NADAC publication: 10/19/2016
Product Information
COMBIVIR TABLET is a brand product labeled by ViiV Healthcare Company, priced at $14.3948 per EA under NDC 49702020218. Its NADAC has been published 208 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the lamivudine and zidovudine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
150; 300 mg/1; mg/1
Manufacturer
ViiV Healthcare CompanyNDC
49702020218
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
10/19/2016
Active Ingredients
LAMIVUDINE; ZIDOVUDINEApproval Type
New Drug (NDA)
FDA Application
NDA020857On Market Since
10/19/2010
Pharmacological Classes
Price Statistics
The NADAC for COMBIVIR TABLET has been published 208 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.3948 per EA |
|---|---|
| All-time high | $14.6526 (Nov 12, 2014) |
| All-time low | $13.8466 (Nov 19, 2014) |
| Median price | $14.4711 |
| Average price | $14.4676 |
| Largest weekly change | -5.5% (Nov 19, 2014) |
| Weeks tracked | 208 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the lamivudine and zidovudine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of COMBIVIR TABLET?
The current National Average Drug Acquisition Cost (NADAC) for COMBIVIR TABLET, manufactured by ViiV Healthcare Company, is $14.3948 per EA (NDC 49702020218), effective Nov 15, 2017.
How has the price of COMBIVIR TABLET changed over time?
Over the history we have for it, the NADAC for COMBIVIR TABLET has held within roughly two percent of its current level. It has been tracked across 208 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for COMBIVIR TABLET?
Since Nov 28, 2013, the NADAC for COMBIVIR TABLET has ranged from a low of $13.8466 (Nov 19, 2014) to a high of $14.6526 (Nov 12, 2014), with a median of $14.4711 per EA.
Are there cheaper alternatives to COMBIVIR TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of COMBIVIR TABLET, so no direct lower-cost alternative is listed.
Who manufactures COMBIVIR TABLET?
COMBIVIR TABLET (NDC 49702020218) is labeled by ViiV Healthcare Company, and CMS classifies it as a brand product.
Related Drugs
Same classification